Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Gil Price

MetaVia Inc. reported in an 8-K filed January 18, 2023 that Gil Price resigned as Chief Executive Officer and President, effective January 12, 2023. The proxy statement of MetaVia Inc. reports total compensation of $116,807 for Gil Price in fiscal 2023, including a base salary of $16,667. Disclosed compensation is on record for 4 fiscal years.

“On January 12, 2023, Gil Price, M.D. resigned as Chief Executive Officer and President of NeuroBo Pharmaceuticals, Inc., a Delaware corporation (the "Company"), effective immediately.”
MetaVia Inc. Form 8-K, filed January 18, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at MetaVia Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 MetaVia Inc. (MTVA) $16,667 $116,807
2022 MetaVia Inc. (MTVA) $400,000 $501,579
2021 MetaVia Inc. (MTVA) $66,154 $920,276
2020 MetaVia Inc. (MTVA) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.